Partners

Chiome Bioscience a biotechnology company with its focus on discovery and development of antibody-based therapeutics in the disease area where high unmet medical needs exist, such like oncology, immunology, CNS, and inflammatory. It has several programs in discovery and preclinical stage in these fields. Chiome owns proprietary antibody generating technology named ADLib® System, together with currently available platforms. It was founded in 2005 and is listed on Tokyo stock exchange Mothers (code: 4583), and is located in Tokyo, Japan.

Senju Pharmaceutical Co.,Ltd. develops pharmaceutical products for eye, ear, nose, throat, and skin care. It offers prescription drugs in various categories, such as inflammation, allergy, glaucoma, cataract, infection, surgical aid, and cornea protection. The company also offers over-the-counter products. It serves customers in Asia, North and South America, Europe, and the Middle East. Senju Pharmaceutical Co.,Ltd. was founded in 1947 and is based in Osaka, Japan.

Immune Biosolutions is an innovative biotech company focused on the discovery and engineering of transformational chicken antibodies targeting difficult proteins with a validated, yet unexploited, therapeutic potential.

1 Westmount Square, Suite 800
Montreal, Quebec H3Z 2P9
Canada

Business Development: bd@semathera.com
Human Resources: careers@semathera.com
General Inquiries: info@semathera.com

© Copyright 2018 SemaThera Inc.